Literature DB >> 10329480

The DPL1 gene is involved in mediating the response to nutrient deprivation in Saccharomyces cerevisiae.

D Gottlieb1, W Heideman, J D Saba.   

Abstract

Sphingosine-1-phosphate is a sphingolipid metabolite involved in the regulation of cell proliferation in mammalian cells. The major route of sphingosine-1-phosphate degradation is through cleavage at the C, bond by sphingosine phosphate lyase. The recent identification of the first dihydrosphingosine/sphingosine phosphate lyase gene in Saccharomyces cerevisiae establishes that phosphorylated sphingoid base metabolism is conserved throughout evolution. The dpl1delta deletion mutant, which accumulates endogenous phosphorylated sphingoid bases, exhibits unregulated proliferation upon approach to stationary phase. The increased proliferation rate during respiratory growth was associated with failure to appropriately recruit cells into the G1 phase of the cell cycle. Several genes were found to be overexpressed or prematurely expressed during nutrient deprivation in the dpl1delta strain, including glucose-repressible genes and G1 cyclins. These studies implicate a role for DPL1 and phosphorylated sphingoid bases in the regulation of global responses to nutrient deprivation in yeast.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329480     DOI: 10.1006/mcbr.1999.0109

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  27 in total

Review 1.  Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.

Authors:  S-K Jo; A Bajwa; A S Awad; K R Lynch; M D Okusa
Journal:  Kidney Int       Date:  2008-03-05       Impact factor: 10.612

Review 2.  PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism.

Authors:  Florence Bourquin; Guido Capitani; Markus Gerhard Grütter
Journal:  Protein Sci       Date:  2011-09       Impact factor: 6.725

3.  Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications.

Authors:  Andreas R Janecke; Ruijuan Xu; Elisabeth Steichen-Gersdorf; Siegfried Waldegger; Andreas Entenmann; Thomas Giner; Iris Krainer; Lukas A Huber; Michael W Hess; Yaacov Frishberg; Hila Barash; Shay Tzur; Nira Schreyer-Shafir; Rivka Sukenik-Halevy; Tania Zehavi; Annick Raas-Rothschild; Cungui Mao; Thomas Müller
Journal:  Hum Mutat       Date:  2017-03-06       Impact factor: 4.878

4.  Accumulation of phosphorylated sphingoid long chain bases results in cell growth inhibition in Saccharomyces cerevisiae.

Authors:  S Kim; H Fyrst; J Saba
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

5.  Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death.

Authors:  S M Mandala; R Thornton; I Galve-Roperh; S Poulton; C Peterson; A Olivera; J Bergstrom; M B Kurtz; S Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 6.  Yeast sphingolipids: recent developments in understanding biosynthesis, regulation, and function.

Authors:  L Ashley Cowart; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2006-08-10

7.  Identification of C18:1-phytoceramide as the candidate lipid mediator for hydroxyurea resistance in yeast.

Authors:  Nabil Matmati; Alessandra Metelli; Kaushlendra Tripathi; Shuqi Yan; Bidyut K Mohanty; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2013-04-25       Impact factor: 5.157

Review 8.  Fifty years of lyase and a moment of truth: sphingosine phosphate lyase from discovery to disease.

Authors:  Julie D Saba
Journal:  J Lipid Res       Date:  2019-01-11       Impact factor: 5.922

9.  A computational approach to the inference of sphingolipid pathways from the genome of Aspergillus fumigatus.

Authors:  Jin Hwan Do; Tae-Kyu Park; Dong-Kug Choi
Journal:  Curr Genet       Date:  2005-09-14       Impact factor: 3.886

Review 10.  Lyase to live by: sphingosine phosphate lyase as a therapeutic target.

Authors:  Ashok Kumar; Julie D Saba
Journal:  Expert Opin Ther Targets       Date:  2009-08       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.